Bornea, Baby Boy .

HRN: 21-94-84  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/19/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/19/2022
09/26/2022
IV
48mg
Q24h
Neonatal Depression, R/o Hie
Waiting Final Action 
09/19/2022
AMPICILLIN 250MG (VIAL)
09/19/2022
09/26/2022
IV
240mg
Q12
Neonatal Depression, R/o Hie
Waiting Final Action 
09/21/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/21/2022
09/27/2022
IV
24mg
Q8
NEC
Waiting Final Action 
09/21/2022
CEFOTAXIME 500MG (VIAL)
09/21/2022
09/27/2022
IV
320mg
Q12
NEC
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: